CellVax receives FDA clearance for prostate cancer drug trial

CellVax receives FDA clearance for prostate cancer drug trial

Submitted by admin on January 30, 2024 - 10:47am
Source: 
Clinical Trials Arena
News Tags: 
CellVax Therapeutics
FDA
FK-PC101
prostate cancer
clinical trials
Headline: 
CellVax receives FDA clearance for prostate cancer drug trial
snippet: 

The US Food and Drug Administration (FDA) has approved an investigational new drug application (IND) from CellVax Therapeutics to begin a Phase II clinical trial for FK-PC101.

Do Not Allow Advertisers to Use My Personal information